Shimon Shteingart
Overview
Explore the profile of Shimon Shteingart including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Skorochod R, Raveh D, Wiener-Well Y, Fteiha B, Shteingart S, Skorochod Y
Isr Med Assoc J
. 2022 Oct;
24(10):643-648.
PMID: 36309859
Background: The hepatobiliary system is a sterile micro-environment. Bacterial infection in this system is most commonly associated with anaerobes as well as gram-positive and gram-negative bacteria. Biliary infections with Staphylococcus...
2.
Kozlova D, Gilboa Y, Sade-Zalts C, Gielchinsky Y, Shteingart S, Kidron D
Pediatr Dev Pathol
. 2021 Mar;
24(4):383-387.
PMID: 33749381
Fetal urinoma is defined as an encapsulated accumulation of extravasated urine within the perirenal space or retroperitoneum. It is an uncommon finding in prenatal practice, and the vast majority of...
3.
Skorochod R, Shteingart S, Nesher G
Am J Med
. 2021 Feb;
134(3):e235.
PMID: 33637191
No abstract available.
4.
Bar-Gil Shitrit A, Chen-Shuali C, Adar T, Koslowsky B, Shteingart S, Paz K, et al.
Dig Dis Sci
. 2018 Jul;
63(11):2992-2997.
PMID: 30027514
Background: Poor sleep quality is associated with adverse health consequences. Sleep disturbances can impact the immune function and inflammatory processes. Little is known about sleep disturbances in patients with inflammatory...
5.
Resnick E, Shteingart S, Melamud B, Bdolah-Abram T, Zalut T, Reuben A, et al.
World J Hepatol
. 2017 Jan;
8(36):1629-1636.
PMID: 28083086
Aim: To evaluate the diagnostic value of serial biochemical blood tests in the diagnosis of biliary colic. Methods: Files were reviewed of 1039 patients who were admitted to the Share'e...
6.
Dotan I, Levy-Nissenbaum E, Chowers Y, Fich A, Israeli E, Adar T, et al.
Dig Dis Sci
. 2016 Aug;
61(11):3246-3254.
PMID: 27572942
Background: Treatment of active ulcerative colitis is associated with incomplete efficacy, adverse events, and loss of response. Toll-like receptor-9 mediates innate and adaptive immune response toward intestinal microorganisms. The oral...
7.
Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report
Hasin Y, Shteingart S, Dahari H, Gafanovich I, Floru S, Braun M, et al.
World J Hepatol
. 2016 Jul;
8(20):858-62.
PMID: 27458506
The United States Food and Drug Administration recently warned that the direct acting antiviral (DAA) combination hepatitis C virus (HCV) treatment of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin (PODr +...
8.
Adar T, Shteingart S, Ben-Yaacov A, Shitrit A, Livovsky D, Shmorak S, et al.
Dig Dis Sci
. 2016 Feb;
61(7):1915-24.
PMID: 26874691
Background: Involvement of eotaxin-1 in inflammatory bowel disease has been previously suggested and increased levels of eotaxin-1 have been described in both ulcerative colitis and in Crohn's disease. The association...
9.
Lurie Y, Webb M, Cytter-Kuint R, Shteingart S, Lederkremer G
World J Gastroenterol
. 2015 Nov;
21(41):11567-83.
PMID: 26556987
The evaluation and follow up of liver fibrosis and cirrhosis have been traditionally performed by liver biopsy. However, during the last 20 years, it has become evident that this "gold-standard"...
10.
Dahari H, Shteingart S, Gafanovich I, Cotler S, DAmato M, Pohl R, et al.
Liver Int
. 2014 Sep;
35(2):289-94.
PMID: 25251042
Background & Aims: Intravenous silibinin (SIL) is a potent antiviral agent against hepatitis C virus (HCV) genotype-1. In this proof of concept case-study we tested: (i) whether interferon-alfa (IFN)-free treatment...